Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
10 /100
LOW RISK
Score updated Oct 13, 2026

REGN — Regeneron Pharmaceuticals, Inc. Dilution Risk Tracker

Track REGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track REGN — Get alerts when the score changes →

As of October 13, 2026, Regeneron Pharmaceuticals, Inc. (REGN) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Regeneron Pharmaceuticals, Inc. has a market capitalization of $71.67B, 93.96M shares outstanding, 1403 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
19
💰Cash Runway—
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for REGN.
🔔 Track REGN — Get forecast alerts →

Market Data

Market Cap$71.67B
Shares Outstanding93.96M
Float97.67M
Cash$7.99B
Debt$3.49B
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore10/100DilutionWatch score record
Shares Outstanding93.96MVerified float table or market cache
Public Float97.67MVerified float table or market cache
Market Cap$71.67BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 4, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.1% shares (2026Q1 vs prior)
1403 institutional holders · 109.10M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 13.31M shares
#2 BlackRock, Inc. 8.95M shares
#3 STATE STREET CORP 4.66M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.15M
Days to Cover2.5
% of Float2.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-02-07
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-03
4 INSIDER TRANSACTION 2026-02-11
4 INSIDER TRANSACTION 2026-02-11
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual REGN Dilution Snapshot

Regeneron Pharmaceuticals, Inc. (REGN) has a DilutionScore of 10/100, rated Low dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

REGN's DilutionScore has held steady at 10/100 (Low risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202610/100LOW89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

REGN shares outstanding have decreased 0.0% from 103.02M (Apr 2026) to 103.02M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 03, 2026103.02M97.67M▼ 2.17%
May 01, 2026103.02M99.84M▲ 1.34%
Apr 28, 2026103.02M98.52M▼ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track REGN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment REGN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking REGN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for REGN
REGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.